Article
Activating Transcription Factor 5 Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance
28 Nov 2023
Abstract excerpt
MYCN-amplified neuroblastoma often presents as a highly aggressive metastatic disease with a poor prognosis. Activating transcription factor 5 (ATF5) is implicated in neural cell differentiation and cancer cell survival. Here, we show that ATF5 is highly expressed in patients with stage 4 high-risk neuroblastoma, with increased expression correlating with a poorer prognosis. We demonstrated that ATF5 promotes the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
